Overview

Have you wondered if genetic counseling/testing is appropriate for your patient? Has your patient received a difficult to interpret genetic test result? Do you have questions about how to manage patients at increased risk for cancer?

The Identifying and Managing Patients at Risk for Cancer ECHO (Extension for Community Health-Care Outcomes) CME series seeks to improve access to knowledge for clinicians in rural and urban areas identifying and managing patients/families at increased risk for cancer. The program will use cost free teleconferencing technologies to facilitate an effective "knowledge network" intended for advanced practice clinicians, family physicians, and others providing care to those with a personal/family history of cancer to enhance their knowledge of genetic testing and screening for cancer syndromes.

Clinicians, genetic counselors, and other allied health professionals will have the opportunity to present patient cases and receive feedback from a multidisciplinary team of experts, including certified genetic counselors. Identifying patients who are at a higher risk for specific cancers can result in increased surveillance or prophylactic risk-reduction that can save lives. Case topics may include, but are not limited to, breast and ovarian cancer and lynch syndrome.

Genetic counselors can help you to make informed, personalized decisions about your genetic health. As genetics professionals, they can help identify your potential genetic health risks, give you information about genetic conditions and inheritance patterns, discuss genetic testing options, help you understand your genetic results, and provide support throughout the process according to the National Society of Genetic Counselors website.

Providers are awarded 1.0 hours of ACCME Category 1 CME credit at no cost for each Identifying and Managing Patients at Risk for Cancer ECHO clinic attended.

To attend or learn more, please contact:

Jordan Holloman 
Program Coordinator 
Email: jordan.holloman@hsc.utah.edu 
Phone: (801) 587-9193

Clinic Times

First & third Tuesdays every month from noon–1:00 (MST)

Clinical Team

Saundra Buys, MD
Co-Director, Family Cancer Assessment Clinic 
Medical Director, High Risk Breast Cancer Clinic, Huntsman Cancer Institute
Professor, Department of Medicine

Whitney Espinel, MS
Genetic Counselor, Intermountain Healthcare

Amanda Gammon, MS
Genetic Counselor, Huntsman Cancer Institute

Jade Grimett, MS
Genetic Counselor, Huntsman Cancer institute

Brent Hafen, MS
Genetic Counselor, Internmountain Healthcare

Jeri Harashima, MS
Genetic Counselor, Intermountain Healthcare

Wendy Kohlmann, MS
Genetic Counselor, Huntsman Cancer Institute

Jordan Holloman
Program Coordinator
Email: jordan.holloman@hsc.utah.edu
Phone: (801) 587-9193

Forms

Resources

Clinical Updates

DateTopicPresented By
November 3, 2015 Talking to Patients About Hereditary Cancer Intermountain Healthcare
November 17, 2015 Addressing Patient Anxiety: Before and After Genetic Testing Huntsman Cancer Institute
December 1, 2015 Dealing with Variants of Uncertain Significance in the Clinic Intermountain Healthcare
December 15, 2015 Updates from the San Antonio Breast Cancer Symposium: Hereditary Cancer Huntsman Cancer Institute
January 5, 2016 Genetic Testing Logistics: Laboratories and Insurance Intermountain Healthcare
January 19, 2016 Updates from the San Antonio Breast Cancer Symposium Huntsman Cancer Institute
February 2, 2016 Identifying Patients at Risk for Hereditary Cancer: Genetic Counseling Referral Tools Intermountain Healthcare
February 16, 2016 Family History Collection: Tips and Tools Huntsman Cancer Institute
March 1, 2016 Negative Genetic Test Results: Now What? Intermountain Healthcare
March 15, 2016 Breast Cancer Risk Assessment Models Huntsman Cancer Institute
April 5, 2016 Updates from the 2016 American College of Medical Genetics and Genomics (ADMG) Annual Clinical Genetics Meeting Intermountain Healthcare
April 19, 2016 High/Moderate Risk Gene Spotlight Series: MSH6 and PMS2 Huntsman Cancer Institute
May 3, 2016 Identifying Patients at Risk for Lynch Syndrome Based on Tumor Screening Results  Intermountain Healthcare
May 17, 2016 Updates from the Hereditary Breast Cancer Conference in Montreal Huntsman Cancer Institute
June 7, 2016 Family History Collection Tools Intermountain Healthcare
June 21, 2016 High/Moderate Risk Gene Spotlight Series: CHEK2 Huntsman Cancer Institute
July 5, 2016 Hereditary Cancer Panels: What to Expect? Intermountain Healthcare
July 19, 2016 Use of Breast Cancer Risk Reducing Medication in High Risk Women (Sarah Colonna, MD) Huntsman Cancer Institute
August 2, 2016 Genetic Information Nondiscrimination Act Intermountain Healthcare
August 16, 2016 Breast MRI and Familial Breast Cancer Huntsman Cancer Institute
September 6, 2016 How to Get Your Office Set Up for Genetic Testing? Intermountain Healthcare
September 20, 2016 High/Moderate Risk Gene Spotlight Series: MSH6 and PMS2 Huntsman Cancer Institute
October 4, 2016 Updates from the 2016 National Society of Genetic Counselors Annual Education Conference Intermountain Healthcare
October 18, 2016 High/Moderate Risk Gene Spotlight Series: CHEK2 Huntsman Cancer Institute

Videos